Baxter Bros Inc
IDXX icon

Baxter Bros Inc’s Idexx Laboratories IDXX Stock Holding History

Baxter Bros Inc’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$893K Sell
1,710
-13
-0.8% -$7.12K 0.1% 101
2026
Q2 		$907K Buy
1,723
+13
+0.8% +$7.29K 0.1% 98
2026
Q1 		$961K Hold
1,710
– – 0.12% 91
2025
Q4 		$1.16M Hold
1,710
– – 0.13% 86
2025
Q3 		$1.09M Hold
1,710
– – 0.13% 85
2025
Q2 		$917K Hold
1,710
– – 0.11% 89
2025
Q1 		$718K Hold
1,710
– – 0.09% 95
2024
Q4 		$707K Hold
1,710
– – 0.09% 94
2024
Q3 		$864K Hold
1,710
– – 0.11% 85
2024
Q2 		$833K Sell
1,710
-570
-25% -$286K 0.11% 82
2024
Q1 		$1.23M Hold
2,280
– – 0.16% 75
2023
Q4 		$1.27M Hold
2,280
– – 0.18% 72
2023
Q3 		$997K Hold
2,280
– – 0.15% 79
2023
Q2 		$1.15M Hold
2,280
– – 0.17% 74
2023
Q1 		$1.14M Hold
2,280
– – 0.18% 73
2022
Q4 		$930K Hold
2,280
– – 0.15% 75
2022
Q3 		$743K Buy
2,280
+400
+21% +$147K 0.13% 78
2022
Q2 		$659K Hold
1,880
– – 0.12% 81
2022
Q1 		$1.03M Hold
1,880
– – 0.15% 73
2021
Q4 		$1.24M Hold
1,880
– – 0.18% 71
2021
Q3 		$1.17M Hold
1,880
– – 0.19% 69
2021
Q2 		$1.19M Hold
1,880
– – 0.19% 67
2021
Q1 		$920K Hold
1,880
– – 0.16% 70
2020
Q4 		$940K Hold
1,880
– – 0.18% 70
2020
Q3 		$739K Sell
1,880
-50
-3% -$18.5K 0.16% 70
2020
Q2 		$637K Sell
1,930
-170
-8% -$49.2K 0.15% 72
2020
Q1 		$509K Hold
2,100
– – 0.13% 78
2019
Q4 		$548K Buy
+2,100
New +$553K 0.11% 85

Other funds holding IDXX

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Baxter Bros Inc's IDXX Position: Q3 2026 in Review

Baxter Bros Inc reduced its Idexx Laboratories (IDXX) stake by 0.75% in Q3 2026, selling an estimated $7.12K and leaving 1,710 shares worth $893K. The position accounts for 0.1% of the portfolio, ranked #101.

Baxter Bros Inc first reported a position in IDXX in Q4 2019 and has held it in 28 quarters since. The position peaked at $1.27M in Q4 2023. 1,073 funds tracked by Wall St. Rank hold IDXX as of Q3 2026.

  • Baxter Bros Inc held 1,710 shares of Idexx Laboratories worth $893K as of Q3 2026.
  • Baxter Bros Inc sold 13 Idexx Laboratories shares in Q3 2026, an estimated $7.12K.
  • Idexx Laboratories made up 0.1% of Baxter Bros Inc's portfolio in Q3 2026, its #101 holding.
  • Baxter Bros Inc first reported a position in Idexx Laboratories in Q4 2019 and has held it in 28 quarters since.
  • Baxter Bros Inc's Idexx Laboratories position peaked at $1.27M in Q4 2023.
  • 1,073 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2026.

Based on Baxter Bros Inc's 13F filing for Q3 2026, filed 4 Nov 2026.